www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Stirling Products in trading halt pending acquisition announcement
Stirling Products (ASX: STI) has requested a trading halt pending release of an announcement about the acquisition of a controlling interest in TeleMedCare Holdings Pty Ltd, an e-health and tele-health business with current operations in Australia, New Zealand and the United Kingdom.
The halt will last until an announcement is made or commencement of trading on Tuesday 3rd August 2010.


















